Future Medicine Ltd., part of Future Science Group, UK, has announced the launch of a new bimonthly title, Neurodegenerative Disease Management. The journal will be published by Future Medicine Ltd (UK, London), known for its collection of journals providing healthcare practitioners and research professionals with a unique source of objective, cutting-edge information on exciting trends emerging in light of advances in medicine, healthcare and clinical practice.
Articles published in Neurodegenerative Disease Management will address all the latest trends in the field, from R&D through to clinical application and management, presenting research, findings, analysis and commentaries from experts around the world. The journal will provide guidance to the multidisciplinary disease management community regarding the most effective treatment strategies and the implications of cutting-edge research as it emerges.
In addition, the journal provides concise and clear coverage of topics at the forefront of research, which impact the understanding, treatment and management of major neurodegenerative diseases. Articles take the form of reviews, analysis and original articles which cover a broad range of topics including all neurodegenerative diseases; from Alzheimers to multiple sclerosis, disease mechanisms, epidemiology, genetic and environmental influences on disease pathogenesis, pharmacoeconomics, outcomes research, quality of life and much more.
Articles are subject to peer-review by three independent referees on a double-blind basis. Authors publishing in the journal are asked to disclose any professional or financial interest that may be perceived as causing a conflict of interest in the context of the article.
Anthony HV Schapira of the UCL Institute of Neurology, UK, and Bruno Dubois of the hôpital La Salpêtrière, France, are in charge of the editorial direction of Neurodegenerative Disease Management acting as Associate Editors. They will be supported by a team of international experts making up the editorial advisory board.
Search for more Medical Journals
To access our daily STM news feed through your iPhone, iPad, or other smartphones, please visit www.myscoope.com for a mobile friendly reading experience.
